A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects

Inclusion Criteria: * Subject understands and voluntarily signs a written informed consent form (ICF). * Healthy male or female subjects aged 18-45 years (inclusive) at the time of signing informed consent. * The body mass index (BMI) at screening was in the range of 18.5\~28.0kg/m2 (inclusive). * Female subjects must meet the following conditions: no fertility (e.g. documented hysterectomy, bilateral transfusion; Blood pregnancy detection knot during ovular tubule resection or ligation, or menopause for more than 1 year), or screening of fertile persons' results were negative, and they were willing to use strict and effective contraceptive methods (such as medication or barrier methods) during the study period. Male subjects were required to consent to a strict and effective form of contraception. · Subjects are willing and able to complete the procedures and examinations associated with the trial, and can maintain a stable diet, exercise and ohter lifestyle habits during the trial. Exclusion Criteria: * Subjects' forearm skin could not be stimulated by capsaicin, or was unresponsive or abnormally responsive to capsaicin stimulation. * There is medical history or clinical evidence that the subject has a serious acute or chronic illness (including, but not limited to: Heart, kidney, nerve, endocrine, blood, immune, infection, metabolic dysfunction, etc.), by investigator judged that participating in the study could confound the results or put the subjects at risk. * T…